HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 21 May 2013

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  21 papers were listed this time. Here's a few in our areas of research interest:

Twice each month we highlight recently published cost utility studies and selected reviews and editorials.

Suter LG, Paltiel AD, Rome BN, et al. Placing a price on medical device innovation: the example of total knee arthroplasty. PLoS One. 2013 May 6;8(5):e62709. Print 2013. PubMed PMID: 23671626.

van Gils CW, de Groot S, Redekop WK, et al. Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence. Pharmacoeconomics. 2013 May 9. [Epub ahead of print] PubMed PMID: 23657918.

Chesson HW, Bernstein KT, Gift TL, et al. The Cost-Effectiveness of Screening Men Who Have Sex With Men for Rectal Chlamydial and Gonococcal Infection to Prevent HIV Infection. Sex Transm Dis. 2013 May;40(5):366-71. PubMed PMID: 23588125.